Bioequivalence of a Dosage form of the New Drug Mefebut
- Authors: Smirnova L.A.1,2, Suchkov E.A.1,2, Ryabukha A.F.1,2, Kuznetsov K.A.1,2, Velikopol’skaya M.V.1, Tyurenkov I.N.1, Bakulin D.A.1, Stepanova É.F.3, Shevchenko A.M.3
- 
							Affiliations: 
							- Volgograd State Medical University
- Volgograd Medical Scientific Center
- Pyatigorsk Medico-Pharmaceutical Institute, Branch of Volgograd State Medical University
 
- Issue: Vol 52, No 6 (2018)
- Pages: 495-496
- Section: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245274
- DOI: https://doi.org/10.1007/s11094-018-1846-x
- ID: 245274
Cite item
Abstract
The bioequivalence of mefebut drug substance and its tablet dosage form was investigated by studying the main pharmacokinetic parameters and calculating the relative bioavailability. The results showed that mefebut circulated for up to 4 h in rabbit blood after peroral administration. The relative bioavailability was 97.4%.
Keywords
About the authors
L. A. Smirnova
Volgograd State Medical University; Volgograd Medical Scientific Center
							Author for correspondence.
							Email: post@volgmed.ru
				                					                																			                												                	Russian Federation, 							1 Pavshikh Bortsov Sq, Volgograd, 400131; 1 Pavshikh Bortsov Sq, Volgograd, 400131						
E. A. Suchkov
Volgograd State Medical University; Volgograd Medical Scientific Center
														Email: post@volgmed.ru
				                					                																			                												                	Russian Federation, 							1 Pavshikh Bortsov Sq, Volgograd, 400131; 1 Pavshikh Bortsov Sq, Volgograd, 400131						
A. F. Ryabukha
Volgograd State Medical University; Volgograd Medical Scientific Center
														Email: post@volgmed.ru
				                					                																			                												                	Russian Federation, 							1 Pavshikh Bortsov Sq, Volgograd, 400131; 1 Pavshikh Bortsov Sq, Volgograd, 400131						
K. A. Kuznetsov
Volgograd State Medical University; Volgograd Medical Scientific Center
														Email: post@volgmed.ru
				                					                																			                												                	Russian Federation, 							1 Pavshikh Bortsov Sq, Volgograd, 400131; 1 Pavshikh Bortsov Sq, Volgograd, 400131						
M. V. Velikopol’skaya
Volgograd State Medical University
														Email: post@volgmed.ru
				                					                																			                												                	Russian Federation, 							1 Pavshikh Bortsov Sq, Volgograd, 400131						
I. N. Tyurenkov
Volgograd State Medical University
														Email: post@volgmed.ru
				                					                																			                												                	Russian Federation, 							1 Pavshikh Bortsov Sq, Volgograd, 400131						
D. A. Bakulin
Volgograd State Medical University
														Email: post@volgmed.ru
				                					                																			                												                	Russian Federation, 							1 Pavshikh Bortsov Sq, Volgograd, 400131						
É. F. Stepanova
Pyatigorsk Medico-Pharmaceutical Institute, Branch of Volgograd State Medical University
														Email: post@volgmed.ru
				                					                																			                												                	Russian Federation, 							11 Prosp. Kalinina, Pyatigorsk, 357532						
A. M. Shevchenko
Pyatigorsk Medico-Pharmaceutical Institute, Branch of Volgograd State Medical University
														Email: post@volgmed.ru
				                					                																			                												                	Russian Federation, 							11 Prosp. Kalinina, Pyatigorsk, 357532						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					